Christa Liesche Borgman, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| HSP90 Heat-Shock Proteins | 3 | 2012 | 422 | 0.160 |
Why?
|
| Lung Neoplasms | 9 | 2012 | 13448 | 0.130 |
Why?
|
| Quinazolines | 2 | 2009 | 1365 | 0.100 |
Why?
|
| HSP27 Heat-Shock Proteins | 1 | 2012 | 67 | 0.100 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 5 | 2012 | 5388 | 0.090 |
Why?
|
| Mammary Neoplasms, Experimental | 1 | 2012 | 498 | 0.080 |
Why?
|
| Carcinoma, Adenosquamous | 1 | 2009 | 66 | 0.080 |
Why?
|
| Dideoxynucleosides | 1 | 2008 | 135 | 0.080 |
Why?
|
| Down-Regulation | 2 | 2012 | 2926 | 0.070 |
Why?
|
| Receptor, erbB-2 | 2 | 2009 | 2592 | 0.070 |
Why?
|
| Bronchial Neoplasms | 1 | 2007 | 109 | 0.070 |
Why?
|
| Triazoles | 1 | 2012 | 897 | 0.070 |
Why?
|
| Genes, erbB-2 | 1 | 2007 | 160 | 0.070 |
Why?
|
| Quinolines | 2 | 2007 | 769 | 0.060 |
Why?
|
| Sirolimus | 2 | 2009 | 1544 | 0.060 |
Why?
|
| Cell Line, Tumor | 8 | 2012 | 17062 | 0.050 |
Why?
|
| Pyrroles | 1 | 2009 | 1119 | 0.050 |
Why?
|
| Neoplasm Metastasis | 2 | 2010 | 4885 | 0.050 |
Why?
|
| Oncogene Proteins, Fusion | 1 | 2010 | 1608 | 0.050 |
Why?
|
| Xenograft Model Antitumor Assays | 4 | 2012 | 3605 | 0.050 |
Why?
|
| Adenocarcinoma | 2 | 2010 | 6356 | 0.050 |
Why?
|
| Enzyme Inhibitors | 2 | 2010 | 3717 | 0.050 |
Why?
|
| Mutation | 5 | 2009 | 30184 | 0.050 |
Why?
|
| Indoles | 1 | 2009 | 1832 | 0.040 |
Why?
|
| Antineoplastic Agents | 4 | 2012 | 13639 | 0.040 |
Why?
|
| Gene Expression Regulation, Neoplastic | 3 | 2012 | 8603 | 0.040 |
Why?
|
| Angiogenesis Inhibitors | 1 | 2009 | 2046 | 0.040 |
Why?
|
| Pyrimidines | 1 | 2010 | 3044 | 0.040 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 2 | 2009 | 11865 | 0.030 |
Why?
|
| Mice, SCID | 2 | 2012 | 2627 | 0.030 |
Why?
|
| In Situ Nick-End Labeling | 2 | 2008 | 610 | 0.030 |
Why?
|
| Drug Resistance, Neoplasm | 2 | 2009 | 5336 | 0.030 |
Why?
|
| Proteomics | 1 | 2010 | 3910 | 0.030 |
Why?
|
| AMP-Activated Protein Kinases | 2 | 2010 | 594 | 0.030 |
Why?
|
| Protein Kinase Inhibitors | 2 | 2010 | 5693 | 0.030 |
Why?
|
| Mice | 9 | 2012 | 81792 | 0.030 |
Why?
|
| Signal Transduction | 4 | 2010 | 23589 | 0.030 |
Why?
|
| Genomics | 1 | 2010 | 5924 | 0.030 |
Why?
|
| Blotting, Western | 2 | 2012 | 5019 | 0.030 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 2 | 2012 | 4563 | 0.030 |
Why?
|
| Positron-Emission Tomography | 1 | 2008 | 6546 | 0.020 |
Why?
|
| Intramolecular Oxidoreductases | 1 | 2012 | 105 | 0.020 |
Why?
|
| Vascular Endothelial Growth Factor C | 1 | 2012 | 124 | 0.020 |
Why?
|
| Benzoquinones | 1 | 2012 | 198 | 0.020 |
Why?
|
| Proto-Oncogene Proteins p21(ras) | 2 | 2010 | 1761 | 0.020 |
Why?
|
| Protein-Tyrosine Kinases | 2 | 2010 | 2423 | 0.020 |
Why?
|
| Gene Expression Profiling | 3 | 2012 | 9522 | 0.020 |
Why?
|
| Immunohistochemistry | 3 | 2009 | 11007 | 0.020 |
Why?
|
| Lactams, Macrocyclic | 1 | 2012 | 318 | 0.020 |
Why?
|
| Protein Stability | 1 | 2012 | 577 | 0.020 |
Why?
|
| Neovascularization, Pathologic | 2 | 2012 | 2630 | 0.020 |
Why?
|
| TOR Serine-Threonine Kinases | 2 | 2010 | 2056 | 0.020 |
Why?
|
| MAP Kinase Kinase 2 | 1 | 2010 | 92 | 0.020 |
Why?
|
| Fibroblast Growth Factor 2 | 1 | 2012 | 592 | 0.020 |
Why?
|
| Focal Adhesions | 1 | 2010 | 113 | 0.020 |
Why?
|
| Focal Adhesion Protein-Tyrosine Kinases | 1 | 2010 | 182 | 0.020 |
Why?
|
| Animals | 9 | 2012 | 168731 | 0.020 |
Why?
|
| Cell Transdifferentiation | 1 | 2010 | 186 | 0.020 |
Why?
|
| MAP Kinase Kinase 1 | 1 | 2010 | 330 | 0.020 |
Why?
|
| Phosphorylation | 2 | 2010 | 8279 | 0.020 |
Why?
|
| Mitogen-Activated Protein Kinase Kinases | 1 | 2010 | 634 | 0.020 |
Why?
|
| src-Family Kinases | 1 | 2010 | 538 | 0.020 |
Why?
|
| Carboplatin | 1 | 2010 | 789 | 0.020 |
Why?
|
| Mice, Mutant Strains | 1 | 2010 | 1746 | 0.020 |
Why?
|
| Ki-67 Antigen | 1 | 2008 | 627 | 0.020 |
Why?
|
| ras Proteins | 1 | 2010 | 1053 | 0.010 |
Why?
|
| Breast Neoplasms | 1 | 2012 | 21053 | 0.010 |
Why?
|
| Tumor Burden | 1 | 2010 | 1884 | 0.010 |
Why?
|
| Transplantation, Heterologous | 1 | 2012 | 2393 | 0.010 |
Why?
|
| Mice, Nude | 1 | 2010 | 3614 | 0.010 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2012 | 3794 | 0.010 |
Why?
|
| Drug Evaluation, Preclinical | 1 | 2009 | 1332 | 0.010 |
Why?
|
| Cell Adhesion | 1 | 2010 | 3089 | 0.010 |
Why?
|
| Cluster Analysis | 1 | 2010 | 2720 | 0.010 |
Why?
|
| Genetic Engineering | 1 | 2009 | 933 | 0.010 |
Why?
|
| Receptor Protein-Tyrosine Kinases | 1 | 2010 | 1622 | 0.010 |
Why?
|
| Paclitaxel | 1 | 2010 | 1728 | 0.010 |
Why?
|
| Gene Amplification | 1 | 2007 | 1089 | 0.010 |
Why?
|
| RNA Interference | 1 | 2010 | 2828 | 0.010 |
Why?
|
| Protein Kinases | 1 | 2008 | 1611 | 0.010 |
Why?
|
| Up-Regulation | 1 | 2010 | 4136 | 0.010 |
Why?
|
| Vascular Endothelial Growth Factor A | 1 | 2012 | 3504 | 0.010 |
Why?
|
| Phosphatidylinositol 3-Kinases | 1 | 2010 | 2878 | 0.010 |
Why?
|
| Cell Cycle | 1 | 2008 | 2918 | 0.010 |
Why?
|
| Drug Therapy, Combination | 1 | 2010 | 6307 | 0.010 |
Why?
|
| Protein Binding | 1 | 2012 | 9299 | 0.010 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2010 | 2880 | 0.010 |
Why?
|
| Amino Acid Sequence | 1 | 2010 | 13403 | 0.010 |
Why?
|
| Cell Movement | 1 | 2010 | 5192 | 0.010 |
Why?
|
| Mice, Transgenic | 1 | 2010 | 9548 | 0.010 |
Why?
|
| Molecular Sequence Data | 1 | 2010 | 17595 | 0.010 |
Why?
|
| Survival Analysis | 1 | 2010 | 10069 | 0.010 |
Why?
|
| Proto-Oncogene Proteins | 1 | 2010 | 4520 | 0.010 |
Why?
|
| Cell Transformation, Neoplastic | 1 | 2007 | 2839 | 0.010 |
Why?
|
| Cells, Cultured | 1 | 2012 | 18972 | 0.010 |
Why?
|
| Cell Proliferation | 1 | 2012 | 10428 | 0.010 |
Why?
|
| Early Detection of Cancer | 1 | 2008 | 3236 | 0.010 |
Why?
|
| Female | 4 | 2012 | 395961 | 0.010 |
Why?
|
| Apoptosis | 1 | 2008 | 9511 | 0.010 |
Why?
|
| Humans | 6 | 2012 | 765734 | 0.010 |
Why?
|
| Time Factors | 1 | 2012 | 40066 | 0.010 |
Why?
|
| Disease Models, Animal | 1 | 2009 | 18289 | 0.010 |
Why?
|
| Male | 2 | 2012 | 363585 | 0.000 |
Why?
|
| Treatment Outcome | 1 | 2008 | 65180 | 0.000 |
Why?
|